Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The European Stroke Scale

L Hantson1, W De Weerdt, J De Keyser

  • 1FLOK, Laboratory of Neuromotor Rehabilitation, Katholieke Universiteit leuven, Belgium.

Stroke
|November 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chronic inflammatory demyelinating polyneuropathy (CIDP) after cilta-cel therapy.

Blood cancer journal·2025
Same author

[German S1 Guideline Long-/Post-COVID].

Pneumologie (Stuttgart, Germany)·2022
Same author

Differences in neurology residency training programmes across Europe - a survey among the Residents and Research Fellow Section of the European Academy of Neurology national representatives.

European journal of neurology·2020
Same author

[Delirium in idiopathic Parkinson's disease].

Der Nervenarzt·2020
Same author

[Nationwide survey of postgraduate medical training in clinical neurology].

Der Nervenarzt·2018
Same author

Porosity and optical properties of zirconia films prepared by plasma ion assisted deposition.

Applied optics·2017
Same journal

Management of Patients at Risk of Ischemic Stroke With Left Ventricular Systolic Dysfunction in the Absence of Intracardiac Thrombus: A Scientific Statement From the American Heart Association.

Stroke·2026
Same journal

Update on Rehabilitation After Stroke: Global Changes and the Continued Importance of Therapy Intensity, Dose, and Timing.

Stroke·2026
Same journal

ENTF Neuromodulation Yields Reduced Disability After Stroke: An Individual Participant-Level Data Meta-Analysis.

Stroke·2026
Same journal

Menopause and Its Implications for Stroke in Women.

Stroke·2026
Same journal

Physician Approaches to Determining Goals of Stroke Care for Patients Living With Disability or Dementia: Results from the SEED Mixed-Methods Study.

Stroke·2026
Same journal

Aspirin for Stroke Primary Prevention: A Step Toward Genetic-Driven Personalized Medicine.

Stroke·2026
See all related articles

The European Stroke Scale (ESS) is a reliable tool for stroke trials. It demonstrates excellent clinimetric properties for assessing therapeutic effects and matching treatment groups.

Area of Science:

  • Neurology
  • Clinical Trials
  • Psychometrics

Background:

  • A validated scale is crucial for stroke trial efficacy and treatment group matching.
  • The European Stroke Scale (ESS) was developed to meet these clinimetric needs.

Purpose of the Study:

  • To evaluate the clinimetric properties of the European Stroke Scale (ESS).
  • To assess the reliability, validity, and prognostic value of the ESS for middle cerebral artery stroke patients.

Main Methods:

  • The ESS, comprising 14 items, was assessed for interrater and intrarater reliability, internal consistency, and completion time in stroke patients.
  • Concurrent validity was established by correlating the ESS with established scales (MCA, Canadian, Scandinavian Stroke Scales, Barthel Index, Rankin Scale).
  • Prognostic validity was analyzed using linear regression for 1- and 8-month outcomes.

Related Experiment Videos

Main Results:

  • Excellent interrater (kappa 0.62-0.85) and intrarater (kappa 0.65-1.00) reliability, and superb internal consistency (Cronbach's alpha 0.92).
  • Mean completion time was 8.2 minutes.
  • Strong correlations were found with other neurological scales (0.93-0.95) and functional scales (0.84 to -0.86).
  • Prognostic validity showed significant predictive power (R2 0.45-0.81, P < .0001).

Conclusions:

  • The European Stroke Scale (ESS) meets rigorous clinimetric criteria.
  • The ESS is a validated and reliable instrument for stroke research and clinical practice.